Skip to content

What is phenohytro?: A Comprehensive Guide to the Combination Medication

3 min read

Phenohytro is a combination prescription medicine containing belladonna alkaloids and phenobarbital. Introduced on December 2, 2015, Phenohytro is used to treat conditions such as irritable bowel syndrome and intestinal ulcers.

Quick Summary

Phenohytro is a combination medication of phenobarbital and belladonna alkaloids for treating stomach and bowel disorders like IBS and ulcers by relaxing the digestive tract muscles and providing mild sedation.

Key Points

  • Combination Drug: Phenohytro is a prescription medication that combines a barbiturate (phenobarbital) with belladonna alkaloids (hyoscyamine, atropine, and scopolamine).

  • Primary Uses: It is prescribed as an adjunctive therapy for conditions like irritable bowel syndrome (IBS), acute enterocolitis, and duodenal ulcers to manage symptoms like cramping and spasms.

  • Dual Mechanism of Action: The belladonna alkaloids provide anticholinergic/antispasmodic effects by relaxing smooth muscles, while phenobarbital offers a mild sedative effect to reduce anxiety.

  • Habit-Forming Potential: Due to the phenobarbital content, the medication may be habit-forming, and abrupt cessation after prolonged use can cause withdrawal symptoms.

  • Common Side Effects: Side effects may include drowsiness, blurred vision, dry mouth, dizziness, and constipation.

  • Major Safety Concerns: Warnings include the potential for heat prostration (decreased sweating) and serious adverse effects on the central nervous system or cardiovascular system.

  • Significant Drug Interactions: Phenohytro can interact with alcohol, anticoagulants, and hormonal birth control, so patients must disclose all medications to their doctor.

  • Contraindications: Patients with glaucoma, obstructive urinary or intestinal conditions, myasthenia gravis, or severe ulcerative colitis should not take this medication.

In This Article

Introduction to Phenohytro

Phenohytro is a prescription medication used as an adjunctive treatment for gastrointestinal disorders, including irritable bowel syndrome (IBS), acute enterocolitis, and duodenal ulcers. It contains phenobarbital and a mix of belladonna alkaloids and is available as a liquid or tablet. Due to phenobarbital content, it's a controlled substance in some areas.

Composition and Mechanism of Action

Phenohytro contains four active compounds:

  • Phenobarbital: A barbiturate that is a central nervous system depressant and provides mild sedation, which may help with anxiety related to GI symptoms. It can be habit-forming.
  • Belladonna Alkaloids: Derived from the deadly nightshade plant, this mix includes:
    • Hyoscyamine: An anticholinergic that relaxes smooth muscles in the digestive and urinary tracts to reduce cramping and spasms.
    • Atropine: Also an anticholinergic, it relaxes muscles and reduces GI secretions.
    • Scopolamine: Another anticholinergic reducing muscle spasms and secretions in the GI tract.

This combination addresses both the physical symptoms (cramping and spasms) and associated mild anxiety.

Approved Uses and Indications

The FDA classifies Phenohytro's indications as “possibly effective” based on reviews. It is primarily an adjunctive therapy for:

  • Irritable Bowel Syndrome (IBS): Helps relieve cramping and spasms.
  • Acute Enterocolitis: Used with other treatments for intestinal inflammation.
  • Duodenal Ulcer: May be helpful as adjunctive therapy, though its impact on healing isn't conclusive.

Side Effects and Safety Considerations

Phenohytro has potential side effects and warnings.

Common and Serious Adverse Effects

Common side effects include:

  • Dry mouth, nose, or throat
  • Blurred vision and light sensitivity
  • Drowsiness, dizziness, or weakness
  • Constipation
  • Nausea, vomiting, and bloating

Seek immediate medical help for serious side effects such as:

  • Severe allergic reactions.
  • Confusion, agitation, depression, or unusual excitement.
  • Fast or pounding heartbeats.
  • Difficulty urinating.
  • Heat prostration due to decreased sweating.

Contraindications and Warnings

Avoid Phenohytro with conditions like glaucoma, obstructive uropathy, obstructive GI disease, myasthenia gravis, severe ulcerative colitis, acute intermittent porphyria, or hypersensitivity to ingredients. Be aware of phenobarbital's habit-forming potential. The drug can cause drowsiness and blurred vision. Do not stop taking it suddenly after long-term use; withdrawal should be doctor-supervised.

Drug Interactions

Phenohytro can interact with many medications. Inform your doctor of all products you use. Interactions include:

  • Alcohol and Other CNS Depressants: Increased sedation.
  • Oral Contraceptives: Reduced effectiveness; use backup contraception.
  • Antacids: Decreased absorption of Phenohytro; take 2-3 hours apart.
  • Anticoagulants: Phenobarbital may decrease their effect.

Phenohytro vs. Donnatal

Phenohytro is a brand name for a combination also available as Donnatal or generic versions.

Feature Phenohytro Donnatal
Active Ingredients Phenobarbital, Hyoscyamine, Atropine, Scopolamine Phenobarbital, Hyoscyamine, Atropine, Scopolamine
Forms Elixir and Tablet Elixir and Tablet
FDA Status FDA has not evaluated for efficacy since older approvals Not officially FDA-approved due to pre-1962 market entry, rated "possibly effective"
Controlled Substance Status Considered a controlled substance (Schedule IV) in some states Considered a controlled substance (Schedule IV) in some states

The Controlled Substance Factor

Phenohytro is a Schedule IV controlled substance due to phenobarbital, which has potential for misuse and dependence. However, the combination product is considered less restrictive federally than phenobarbital alone. State laws may vary. Proper prescribing and patient education on risks are crucial.

Conclusion

Phenohytro is a combination medication for symptoms of GI conditions like IBS and ulcers, using phenobarbital and belladonna alkaloids for sedative and antispasmodic effects. It is important to be aware of potential side effects, drug interactions, and the risk of dependence. Always follow your doctor's instructions and discuss concerns for safe use. Consult pharmaceutical resources or your healthcare professional for more details.

Frequently Asked Questions

Yes, Phenohytro contains the same active ingredients (phenobarbital, hyoscyamine, atropine, and scopolamine) as the brand name medication Donnatal.

Yes, due to its phenobarbital content, Phenohytro is classified as a Schedule IV controlled substance by federal law, and some state laws may differ.

Phenohytro is used to treat symptoms associated with stomach and bowel disorders, such as irritable bowel syndrome (IBS), acute enterocolitis, and intestinal ulcers.

The belladonna alkaloids provide anticholinergic and antispasmodic effects by relaxing gastrointestinal muscles and reducing secretions, while the phenobarbital acts as a mild sedative.

Common side effects include drowsiness, blurred vision, dry mouth, dizziness, constipation, and decreased sweating.

No, you should avoid drinking alcohol, as it can increase the sedative effects of the phenobarbital in Phenohytro and cause dangerous side effects.

The FDA rates Phenohytro as "possibly effective" because the medication was on the market before efficacy requirements were in place in 1962, and its efficacy has not been fully established through subsequent studies.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.